Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Yarrow Bioscience, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- 0 vs. Q3 2022
- Shares held
- 7.35M
- −910.6K (−11.0%) vs. Q3 2022
- Total value
- $1.10M
- −$737.7K (−40.1%) vs. Q3 2022
- New holders
- 4
- 5 more added
- Sold out
- 4
- 16 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 171 | $0 | 0.00% | −10−5.5% | Reduced |
| Royal Bank of Canada | 774 | $0 | 0.00% | +129+20.0% | Added |
| Rockefeller Capital Management L.P. | 64 | $0 | 0.00% | −1,300−95.3% | Reduced |
| Investors Research Corp | 150 | $23 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 630 | $95 | 0.00% | −450−41.7% | Reduced |
| Northwestern Mutual Wealth Management Co | 875 | $131 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,565 | $235 | 0.00% | −990−38.7% | Reduced |
| Federated Hermes, Inc. | 2,295 | $344 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 2,557 | $383 | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 3,375 | $506 | 0.00% | 00.0% | Unchanged |
| Tobias Financial Advisors, Inc. | 11,000 | $1.65K | 0.00% | +11,000 | New |
| Mariner, LLC | 12,500 | $2.00K | 0.00% | −1,462−10.5% | Reduced |
| StoneX Group Inc. | 13,837 | $2.08K | 0.00% | +13,837 | New |
| Susquehanna International Group, LLP | 16,484 | $2.47K | 0.00% | −8,444−33.9% | Reduced |
| LPL Financial LLC | 16,912 | $2.54K | 0.00% | −400−2.3% | Reduced |
| Jane Street Group, LLC | 18,469 | $2.77K | 0.00% | −32,158−63.5% | Reduced |
| MB, Levis & Associates, LLC | 18,750 | $2.81K | 0.00% | +18,750 | New |
| Two Sigma Securities, LLC | 18,901 | $2.83K | 0.00% | +18,901 | New |
| Morgan Stanley | 23,347 | $3.50K | 0.00% | −300−1.3% | Reduced |
| CSS LLC | 24,131 | $3.62K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 26,626 | $3.99K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 25,811 | $4.00K | 0.00% | −1,471−5.4% | Reduced |
| Deltec Asset Management LLC | 30,000 | $4.50K | 0.00% | 00.0% | Unchanged |
| Thrivent Financial for Lutherans | 55,064 | $8.00K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 53,954 | $8.09K | 0.00% | −32,658−37.7% | Reduced |
| UBS Group AG | 54,674 | $8.20K | 0.00% | +44,217+422.8% | Added |
| Staley Capital Advisers Inc | 62,500 | $9.00K | 0.00% | 00.0% | Unchanged |
| Beacon Pointe Advisors, LLC | 74,000 | $11.1K | 0.00% | −1,000−1.3% | Reduced |
| Bank of America Corp | 88,808 | $13.3K | 0.00% | +130+0.1% | Added |
| Northern Trust Corp | 89,472 | $13.4K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 96,134 | $14.4K | 0.00% | 00.0% | Unchanged |
| Cetera Advisor Networks LLC | 115,000 | $17.3K | 0.00% | 00.0% | Unchanged |
| Mackenzie Financial Corp | 134,920 | $20.2K | 0.00% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 135,395 | $20.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 210,046 | $31.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 449,085 | $67.0K | 0.00% | −1,118−0.2% | Reduced |
| Millennium Management LLC | 488,012 | $73.0K | 0.00% | +289,298+145.6% | Added |
| Renaissance Technologies LLC | 866,827 | $130.0K | 0.00% | −62,177−6.7% | Reduced |
| BlackRock Inc. | 885,833 | $132.9K | 0.00% | −1,480−0.2% | Reduced |
| DSC Advisors, L.P. | 1,570,000 | $235.5K | 0.54% | −1,100,000−41.2% | Reduced |
| Vanguard Group Inc | 1,650,607 | $247.6K | 0.00% | +1,118+0.1% | Added |
| Virtu Financial LLC | 0 | $0 | 0.00% | −61,464−100.0% | Sold out |
| Howe & Rusling Inc | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Axiom Investment Management LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |